30Oct
[Video] I Wish I Knew What I Know Now: Conversations with AGG on FDA Issues - Key Due Diligence Issues to Consider When Acquiring or Investing in Life Sciences Companies or Products
AGG is pleased to present the second episode in a podcast series titled, “I Wish I Know What I Know Now: Conversations with AGG on FDA Issues,” covering key due diligence issues to consider when acquiring or investing in life science companies or products. In this episode, AGG partner Alan G. Minsk and Brian A. Teras provides an overview of the diligence process, potential red flags, common mistakes, and other factors to consider during the due diligence process. Each month, we'll release a...
By:
Arnall Golden Gregory LLP
Related
In Pennsylvania, the Workers’ Compensation Act is considered a remedial act that is to be liberally...
Read More >
1. The National Labor Relations Board (NLRB) has adopted a new standard for determining whether cont...
Read More >
Brent A. Morowitz, of counsel in the Corporate and Securities Practice Group of Pepper, was intervie...
Read More >
Des Plaines Limousine Service Refused to Hire Applicant Because He Is Deaf, Federal Agency Charged -...
Read More >
As noted previously in EmployNews, Section 7 of the National Labor Relations Act protects concerted ...
Read More >
TLS Dubai’s Iustina Alban jumped on a Zoom call with Paula Boast from Charles Russell Speechlys Bah...
Read More >